what are the potential side effects of glp-1 drugs Part 2 a 3-Part Series; Medications for Weight Loss The GLP-1 Agonists and Obesity:
Description
R (version 4.3.1
[DOI] [PMC free article] [PubMed] [Google Scholar] 106.Feehan J., Mack A., Tuck C., et al
As such, discussion of absorption is less applicable
What is the mechanism driving the reduction of cardiovascular events from glucagon-like peptide-1 receptor agonists?-A mini review
For comorbid metabolic diseases, such as diabetes and obesity, the use of GLP-1RAs generally does not increase cancer risk and may offer certain benefits
